TABLE OF CONTENTS
Volume 37, Issue 12 (June (2) 2006)
Special Report
EBMT activity survey 2004 and changes in disease indication over the past 15 years FREE
A Gratwohl, H Baldomero, K Frauendorfer and A Urbano-Ispizua
Bone Marrow Transplant 37: 1069-1085; doi:10.1038/sj.bmt.1705377
Original Articles
Conditioning Regimens
The modification of high-dose therapy shortens the duration of neutropaenia by delay of leucocyte nadir FREE
T Kiefer, W H Krüger, F Schüler, C Lotze, C Hirt and G Dölken
Bone Marrow Transplant 37: 1087-1091; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705390
Autografting
Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience FREE
E Jantunen, M Itälä, T Siitonen, E Juvonen, E Koivunen, P Koistinen, L Volin, K Remes and T Nousiainen
Bone Marrow Transplant 37: 1093-1098; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705375
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma FREE
S Saraf, Y-H Chen, L C Dobogai, N Mahmud, D Peace, Y Saunthararajah, R Hoffman, S Chunduri and D Rondelli
Bone Marrow Transplant 37: 1099-1102; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705392
Post-Transplant Events
Skin cancer after nonmyeloablative hematopoietic cell transplantation FREE
M Cavalier, J A Shmalo, M Yu, S D Billings, R Abonour and R P Nelson Jr
Bone Marrow Transplant 37: 1103-1108; doi:10.1038/sj.bmt.1705362
Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence FREE
S Shalitin, M Phillip, J Stein, Y Goshen, D Carmi and I Yaniv
Bone Marrow Transplant 37: 1109-1117; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705374
Rapid helper T-cell recovery above 200 
106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation FREE
D H Kim, S K Sohn, D I Won, N Y Lee, J S Suh and K B Lee
Bone Marrow Transplant 37: 1119-1128; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705381
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T-cell depletion: the Leiden experience FREE
R M Y Barge, C W J Starrenburg, J H F Falkenburg, W E Fibbe, E W Marijt and R Willemze
Bone Marrow Transplant 37: 1129-1134; doi:10.1038/sj.bmt.1705385
Graft-versus-Tumor Effects
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma FREE
N W C J van de Donk, N Kröger, U Hegenbart, P Corradini, J F San Miguel, H Goldschmidt, J A Perez-Simon, M Zijlmans, R A Raymakers, V Montefusco, F A Ayuk, M H J van Oers, A Nagler, L F Verdonck and H M Lokhorst
Bone Marrow Transplant 37: 1135-1141; doi:10.1038/sj.bmt.1705393
Graft-versus-Host Disease
Combination antithymocyte globulin and soluble TNF
inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease FREE
G A Kennedy, J Butler, R Western, J Morton, S Durrant and G R Hill
Bone Marrow Transplant 37: 1143-1147; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705380
Letter to the Editor
Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation FREE
U R Deotare, A Vishwabandya, V Mathews, B George, A Srivastava and M Chandy
Bone Marrow Transplant 37: 1149-1150; advance online publication, May 8, 2006; doi:10.1038/sj.bmt.1705378
